NEW YORK (GenomeWeb) – GATC Biotech will offer its clients full access to Qiagen's Ingenuity Variant Analysis solution under a non-exclusive deal announced today by Qiagen. 

Under the terms of the deal, GATC clients will also have access to interpretation services. Ingenuity Variant Analysis is a bioinformatics platform that enables laboratories to evaluate data generated by high-throughput next-generation sequencing technologies. It filters genetic variants in a cloud-based environment to identify those most likely to cause disease. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.